Showing results (501-510 of 587) with videos related to

Sort By:
Pageof 59
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 21, 2021
Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC-an Update From the PACIFIC TrialCorinne Faivre-Finn, David Vicente, Takayasu Kurata, et al.
The New England Journal of Medicine|November 21, 2017
Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung CancerJean-Charles Soria, Yuichiro Ohe, Johan Vansteenkiste, et al.
The New England Journal of Medicine|June 7, 2021
Sotorasib for Lung Cancers with KRAS p.G12C MutationFerdinandos Skoulidis, Bob T Li, Grace K Dy, et al.
BMC Medical Genomics|December 5, 2013
Integrated molecular portrait of non-small cell lung cancersVladimir Lazar, Chen Suo, Cedric Orear, et al.
The New England Journal of Medicine|June 4, 2013
Crizotinib versus chemotherapy in advanced ALK-positive lung cancerAlice T Shaw, Dong-Wan Kim, Kazuhiko Nakagawa, et al.
The Lancet. Oncology|November 11, 2018
Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 studyBenjamin J Solomon, Benjamin Besse, Todd M Bauer, et al.
Lung Cancer (Amsterdam, Netherlands)|June 12, 2022
Exercise in lung Cancer, the healthcare providers opinion (E.C.H.O.): Results of the EORTC lung cancer Group (LCG) surveySara Pilotto, Alice Avancini, Jessica Menis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 2025
Infectious Complications in Patients Treated with T-cell Engagers as Cancer Immunotherapies, A Descriptive Study from the REISAMIC RegistryThomas Hueso, Justin Cagnat, Kaïssa Ouali, et al.
Cells|June 24, 2022
Next-Generation Sequencing on Circulating Tumor DNA in Advanced Solid Cancer: Swiss Army Knife for the Molecular Tumor Board? A Review of the Literature Focused on FDA Approved TestDamien Vasseur, Hela Sassi, Arnaud Bayle, et al.
Diagnostic and Interventional Imaging|June 8, 2025
Baseline CT-derived tumor burden and liquid biopsy as biomarkers to predict survival in patients with metastatic solid cancerGhina Jardali, Littisha Lawrance, Lama Dawi, et al.
Pageof 59